Viking Therapeutics (VKTX) Misses Q2 EPS by 13c

Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($0.58), $0.13 worse than the analyst estimate of ($0.45).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• Stay long AI-capex winners into the peak, Stifel says despite bubble fears
• Conduent launches AI customer service platform with translation tools
• Cosa Resources closes C$12 million bought deal private placement